Positive modulation of the TMEM16B mediated currents by TRPV4 antagonist

Adan Hernandez; Alfredo Alaniz-Palacios; Juan A Contreras-Vite; Ataúlfo Martínez-Torres

doi:10.1016/j.bbrep.2021.101180

Positive modulation of the TMEM16B mediated currents by TRPV4 antagonist

Biochem Biophys Rep. 2021 Dec 2:28:101180. doi: 10.1016/j.bbrep.2021.101180. eCollection 2021 Dec.

Authors

Adan Hernandez¹, Alfredo Alaniz-Palacios¹, Juan A Contreras-Vite¹, Ataúlfo Martínez-Torres¹

Affiliation

¹ Departamento de Neurobiología Celular y Molecular, Laboratorio de Neurobiología Molecular y Celular, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Juriquilla, 76230 Santiago de Querétaro, Querétaro, Mexico.

Abstract

Calcium-activated chloride channels (CaCCs) play important roles in many physiological processes and their malfunction is implicated in diverse pathologies such as cancer, asthma, and hypertension. TMEM16A and TMEM16B proteins are the structural components of the CaCCs. Recent studies in cell cultures and animal models have demonstrated that pharmacological inhibition of CaCCs could be helpful in the treatment of some diseases, however, there are few specific modulators of these channels. CaCCs and Transient Receptor Potential Vanilloid-4 (TRPV4) channels are co-expressed in some tissues where they functionally interact. TRPV4 is activated by different stimuli and forms a calcium permeable channel that is activated by GSK1016790A and antagonized by GSK2193874. Here we report that GSK2193874 enhances the chloride currents mediated by TMEM16B expressed in HEK cells at nanomolar concentrations and that GSK1016790A enhances native CaCCs of Xenopus oocytes. Thus, these compounds may be used as a tool for the study of CaCCs, TRPV4 and their interactions.

Keywords: Calcium-activated chloride channels; TMEM16B channels; TRPV4 antagonist.